Contrast-Associated AKI and Use of Cardiovascular Medications after Acute Coronary Syndrome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Contrast-Associated AKI and Use of Cardiovascular Medications after Acute Coronary Syndrome

Published:2014-10-15 Issue:11 Volume:9 Page:1840-1848
ISSN:1555-9041
Container-title:Clinical Journal of the American Society of Nephrology
language:en
Short-container-title:CJASN

Author:

Leung Kelvin C.W.,Pannu Neesh,Tan Zhi,Ghali William A.,Knudtson Merril L.,Hemmelgarn Brenda R.,Tonelli Marcello,James Matthew T.

Publisher

American Society of Nephrology (ASN)

Subject

Transplantation,Nephrology,Critical Care and Intensive Care Medicine,Epidemiology

Reference45 articles.

1. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention

2. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification

3. Long-term Prognosis of Acute Kidney Injury After Acute Myocardial Infarction

4. Long-term Risk of Mortality and Other Adverse Outcomes After Acute Kidney Injury: A Systematic Review and Meta-analysis

5. Associations Between Acute Kidney Injury and Cardiovascular and Renal Outcomes After Coronary Angiography

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer Treatment in CKD: Time to Move Beyond Renalism;Kidney360;2023-09

2. Cardiovascular Drug Use After Acute Kidney Injury Among Hospitalized Patients With a History of Myocardial Infarction;Kidney International Reports;2023-02

3. Alterations in Practice Because of Contrast-Associated Acute Kidney Injury Following PCI;JACC: Cardiovascular Interventions;2022-05

4. Use of Guideline-Based Therapy for Diabetes, Coronary Artery Disease, and Chronic Kidney Disease After Acute Kidney Injury: A Retrospective Observational Study;Canadian Journal of Kidney Health and Disease;2022-01

5. Angiotensin-Converting Enzyme Inhibitors and Contrast-Associated Acute Kidney Injury After Coronary Angiography and Intervention;American Journal of Cardiovascular Drugs;2020-12-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3